Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cohen

Showing results (1151-1160 of 1,179) with videos related to

Pageof 118
Sort By:
The Journal of Allergy and Clinical Immunology|October 11, 2016
Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescentsJacqueline A Pongracic, Rebecca Z Krouse, Denise C Babineau, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2015
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbationsStephen J Teach, Michelle A Gill, Alkis Togias, et al.
Nature Communications|September 2, 2025
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthmaCourtney L Gaberino, R Max Segnitz, Kimberly A Dill-McFarland, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
The New England Journal of Medicine|August 31, 2016
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Truman J Milling, John W Eikelboom, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis eliminationE Andre, C Isaacs, D Affolabi, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2019
Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthmaKathryn McCauley, Juliana Durack, Ricardo Valladares, et al.
Trials|February 9, 2021
Narrative enhancement and cognitive therapy (NECT) to improve social functioning in people with serious mental illness: study protocol for a stepped-wedge cluster randomized controlled trialJ Dubreucq, M Faraldo, M Abbes, et al.
The Journal of Allergy and Clinical Immunology|July 11, 2024
Home and school pollutant exposure, respiratory outcomes, and influence of historical redliningKyung Hwa Jung, Kira L Argenio, Daniel J Jackson, et al.
The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.
Pageof 118

Showing results (1151-1160 of 1,179) with videos related to

Sort By:
Pageof 118
The Journal of Allergy and Clinical Immunology|October 11, 2016
Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescentsJacqueline A Pongracic, Rebecca Z Krouse, Denise C Babineau, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2015
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbationsStephen J Teach, Michelle A Gill, Alkis Togias, et al.
Nature Communications|September 2, 2025
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthmaCourtney L Gaberino, R Max Segnitz, Kimberly A Dill-McFarland, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
The New England Journal of Medicine|August 31, 2016
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Truman J Milling, John W Eikelboom, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis eliminationE Andre, C Isaacs, D Affolabi, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2019
Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthmaKathryn McCauley, Juliana Durack, Ricardo Valladares, et al.
Trials|February 9, 2021
Narrative enhancement and cognitive therapy (NECT) to improve social functioning in people with serious mental illness: study protocol for a stepped-wedge cluster randomized controlled trialJ Dubreucq, M Faraldo, M Abbes, et al.
The Journal of Allergy and Clinical Immunology|July 11, 2024
Home and school pollutant exposure, respiratory outcomes, and influence of historical redliningKyung Hwa Jung, Kira L Argenio, Daniel J Jackson, et al.
The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.
Pageof 118